Stanislaw Rajmund Burzynski (born January 23, 1943 in Lublin, Poland) is a biochemist and a physician. He is the founder, president, and chairman of Burzynski Research Institute Inc. , based in Houston and Stafford, Texas. Since December 1976, Burzynski administered peptides and their metabolites, which he calls antineoplastons, as a treatment against cancer.
In 1993, Burzynski was brought to court in Texas for treating patients with a therapy not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce. In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons and ordered him to cease and desist selling his products without FDA supervised clinical trials. Burzynski appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity." Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a health insurer for a cancer treatment administered illegally.
Burzynski had a hearing with the Texas Medical Board in April 2012. The FDA had put a partial clinical hold on his clinical trials for pediatric patients which even was extended to all clinical trials six months later. FDA inspections of both Burzynski Clinic and Burzynski Research Institute followed in early 2013. However, FDA lifted these bans again in June 2013, despite damning inspection results establishing a rather sweeping non-compliance with FDA constraints by Burzynski. Meanwhile, the Texas Medical Board is again taking action against Burzynski. One of the latest additions to the list of trangressions, the TMB added the use of health care providers with little or no education or skill and representing them to patients as being doctors.
Main Article: Antineoplaston
- Wikipedia on Antineoplaston
- Wikipedia on Stanislaw Burzynski
- Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee Court judgement
<ref>tag; no text was provided for refs named
Cite error: Invalid
- Template:Cite web
- No. 93-2071 July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.